» Articles » PMID: 23160192

Human SH2B1 Mutations Are Associated with Maladaptive Behaviors and Obesity

Abstract

Src homology 2 B adapter protein 1 (SH2B1) modulates signaling by a variety of ligands that bind to receptor tyrosine kinases or JAK-associated cytokine receptors, including leptin, insulin, growth hormone (GH), and nerve growth factor (NGF). Targeted deletion of Sh2b1 in mice results in increased food intake, obesity, and insulin resistance, with an intermediate phenotype seen in heterozygous null mice on a high-fat diet. We identified SH2B1 loss-of-function mutations in a large cohort of patients with severe early-onset obesity. Mutation carriers exhibited hyperphagia, childhood-onset obesity, disproportionate insulin resistance, and reduced final height as adults. Unexpectedly, mutation carriers exhibited a spectrum of behavioral abnormalities that were not reported in controls, including social isolation and aggression. We conclude that SH2B1 plays a critical role in the control of human food intake and body weight and is implicated in maladaptive human behavior.

Citing Articles

SH2B1 promotes apoptosis in diabetic cataract via p38 MAPK pathway.

Jiang X, Xu L, Xu B, Peng H, Yang T, Zhao Y iScience. 2025; 28(2):111735.

PMID: 39898036 PMC: 11786761. DOI: 10.1016/j.isci.2024.111735.


Endogenous SH2B1 protein localizes to lamellipodia and filopodia: platinum replica electron-microscopy study.

Diakonova M, Carter-Su C, Svitkina T MicroPubl Biol. 2025; 2025.

PMID: 39897164 PMC: 11787627. DOI: 10.17912/micropub.biology.001451.


The expanding landscape of genetic causes of obesity.

Semenova E, Guo A, Liang H, Hernandez C, John E, Thaker V Pediatr Res. 2024; .

PMID: 39690244 DOI: 10.1038/s41390-024-03780-6.


Clinically Meaningful Outcomes after 1 Year of Treatment with Setmelanotide in an Adult Patient with a Variant in SH2B1.

Politei J, Patrono A Obes Facts. 2024; 17(6):646-651.

PMID: 39284294 PMC: 11661841. DOI: 10.1159/000541267.


Obesity: exploring its connection to brain function through genetic and genomic perspectives.

Saeed S, Bonnefond A, Froguel P Mol Psychiatry. 2024; 30(2):651-658.

PMID: 39237720 PMC: 11746128. DOI: 10.1038/s41380-024-02737-9.


References
1.
Robertson S, Leinninger G, Myers Jr M . Molecular and neural mediators of leptin action. Physiol Behav. 2008; 94(5):637-42. PMC: 2516921. DOI: 10.1016/j.physbeh.2008.04.005. View

2.
Yousaf N, Deng Y, Kang Y, Riedel H . Four PSM/SH2-B alternative splice variants and their differential roles in mitogenesis. J Biol Chem. 2001; 276(44):40940-8. DOI: 10.1074/jbc.M104191200. View

3.
Ren D, Zhou Y, Morris D, Li M, Li Z, Rui L . Neuronal SH2B1 is essential for controlling energy and glucose homeostasis. J Clin Invest. 2007; 117(2):397-406. PMC: 1765516. DOI: 10.1172/JCI29417. View

4.
Farooqi I, Keogh J, Yeo G, Lank E, Cheetham T, ORahilly S . Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N Engl J Med. 2003; 348(12):1085-95. DOI: 10.1056/NEJMoa022050. View

5.
Farooqi I, Jebb S, Langmack G, Lawrence E, Cheetham C, Prentice A . Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med. 1999; 341(12):879-84. DOI: 10.1056/NEJM199909163411204. View